Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.21 USD | -6.03% | -13.02% | -34.63% |
Financials (USD)
Sales 2024 * | 30.47M | Sales 2025 * | 71.52M | Capitalization | 1.12B |
---|---|---|---|---|---|
Net income 2024 * | -174M | Net income 2025 * | -127M | EV / Sales 2024 * | 14.5 x |
Net cash position 2024 * | 678M | Net cash position 2025 * | 585M | EV / Sales 2025 * | 7.47 x |
P/E ratio 2024 * |
-5.33
x | P/E ratio 2025 * |
-8.03
x | Employees | 467 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 3.32% |
Latest transcript on Autolus Therapeutics plc
1 day | -6.03% | ||
1 week | -13.02% | ||
Current month | -34.01% | ||
1 month | -33.39% | ||
3 months | -26.66% | ||
6 months | +56.51% | ||
Current year | -34.63% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Pulé
FOU | Founder | 51 | 14-08-31 |
Chief Executive Officer | 59 | 14-09-30 | |
Robert Dolski
DFI | Director of Finance/CFO | 54 | 23-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Berriman
BRD | Director/Board Member | 76 | 14-07-31 |
William Young
BRD | Director/Board Member | 79 | 21-11-14 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 4.21 | -6.03% | 2,720,848 |
24-04-23 | 4.48 | -1.75% | 1,723,804 |
24-04-22 | 4.56 | +0.88% | 1,154,024 |
24-04-19 | 4.52 | -5.83% | 1,407,960 |
24-04-18 | 4.8 | -0.83% | 1,211,739 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.63% | 1.12B | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.86% | 22.2B | |
-16.53% | 21.23B | |
-8.49% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- AUTL Stock